Furman L, Camitta B M, Jaffe N, Sallan S E, Cassady J R, Traggis D, Leavitt P, Nathan D G, Frei E
Med Pediatr Oncol. 1976;2(2):157-66. doi: 10.1002/mpo.2950020205.
The development of an effective therapeutic regimen for acute lymphocytic leukemia (ALL) of childhood is described. By careful surveillance of toxicity and efficacy, positive modifications of treatment strategy were achieved without resorting to classically randomized trails. Teh resultant protocol utilizes vincristine-prednisone induction followed by asparaginase consolidation, intensive intermittent combination maintenance chemotherapy with adriamycin as a major component, and cranial radiotherapy plus intrathecal methotrexate for central nervous system prophylaxis. Preliminary analysis suggests that this regimen may result in prolonged continuous complete remission in at least 80% of children with ALL.
本文描述了针对儿童急性淋巴细胞白血病(ALL)的有效治疗方案的制定。通过对毒性和疗效的仔细监测,在不采用经典随机试验的情况下实现了治疗策略的积极调整。最终方案采用长春新碱-泼尼松诱导治疗,随后进行天冬酰胺酶巩固治疗,以阿霉素为主要成分的强化间歇联合维持化疗,以及用于中枢神经系统预防的颅脑放疗加鞘内注射甲氨蝶呤。初步分析表明,该方案可能使至少80%的ALL患儿实现长期持续完全缓解。